Endovascular therapy for acute intracranial large vessel occlusion due to atherothrombosis : Multicenter historical registry
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ..
BACKGROUND: Atherothrombotic stroke-related large vessel occlusion (AT-LVO) is caused by two etiologies, the intracranial artery occlusion due to in situ occlusion (intracranial group) or due to embolism from cervical carotid occlusion or stenosis (tandem group). The prognosis and reocclusion rate of each etiology after endovascular therapy (EVT) is unclear.
METHODS: We conducted a historical multicenter registry study at 51 Japanese centers to compare the prognoses of AT-LVO between two etiologies. The primary outcome was the incidence of recurrent ischemic stroke or reocclusion of the treated vessels within 90 days after EVT. Each of the primary outcome means the incidence of recurrent ischemic stroke and reocclusion of the treated vessels within 90 days after EVT.
RESULTS: We analyzed 582 patients (338 in the intracranial group and 244 in the tandem group). Patients in the intracranial group were younger (mean 71.9 vs 74.5, p=0.003), more of them were female and fewer of them were current smokers than those in the tandem group. In the tandem group, the patients' National Institutes of Health Stroke Scale score on admission was higher (13 vs 15, p=0.006), onset to puncture time was shorter (299 [145-631] vs 232 [144-459] minutes, p=0.03) and Alberta Stroke Program Early CT Score (ASPECTS) was lower (8 [7-9] vs 8 [6-9], p=0.0002). The primary outcome was higher in the intracranial group (22.5% vs 8.2%, p<0.0001). However, any ICH and death were not significantly different in the two groups.
CONCLUSIONS: The incidence of recurrent ischemic stroke or reocclusion after EVT for AT-LVO was higher in the intracranial group.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Journal of neurointerventional surgery - (2023) vom: 30. Aug. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Uchida, Kazutaka [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 30.08.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1136/jnis-2023-020670 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361462956 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361462956 | ||
| 003 | DE-627 | ||
| 005 | 20231226085206.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/jnis-2023-020670 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1204.xml |
| 035 | |a (DE-627)NLM361462956 | ||
| 035 | |a (NLM)37648433 | ||
| 035 | |a (PII)jnis-2023-020670 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Uchida, Kazutaka |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Endovascular therapy for acute intracranial large vessel occlusion due to atherothrombosis |b Multicenter historical registry |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 30.08.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a BACKGROUND: Atherothrombotic stroke-related large vessel occlusion (AT-LVO) is caused by two etiologies, the intracranial artery occlusion due to in situ occlusion (intracranial group) or due to embolism from cervical carotid occlusion or stenosis (tandem group). The prognosis and reocclusion rate of each etiology after endovascular therapy (EVT) is unclear | ||
| 520 | |a METHODS: We conducted a historical multicenter registry study at 51 Japanese centers to compare the prognoses of AT-LVO between two etiologies. The primary outcome was the incidence of recurrent ischemic stroke or reocclusion of the treated vessels within 90 days after EVT. Each of the primary outcome means the incidence of recurrent ischemic stroke and reocclusion of the treated vessels within 90 days after EVT | ||
| 520 | |a RESULTS: We analyzed 582 patients (338 in the intracranial group and 244 in the tandem group). Patients in the intracranial group were younger (mean 71.9 vs 74.5, p=0.003), more of them were female and fewer of them were current smokers than those in the tandem group. In the tandem group, the patients' National Institutes of Health Stroke Scale score on admission was higher (13 vs 15, p=0.006), onset to puncture time was shorter (299 [145-631] vs 232 [144-459] minutes, p=0.03) and Alberta Stroke Program Early CT Score (ASPECTS) was lower (8 [7-9] vs 8 [6-9], p=0.0002). The primary outcome was higher in the intracranial group (22.5% vs 8.2%, p<0.0001). However, any ICH and death were not significantly different in the two groups | ||
| 520 | |a CONCLUSIONS: The incidence of recurrent ischemic stroke or reocclusion after EVT for AT-LVO was higher in the intracranial group | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Atherosclerosis | |
| 650 | 4 | |a Stroke | |
| 650 | 4 | |a Thrombectomy | |
| 700 | 1 | |a Yamagami, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Sakai, Nobuyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Shirakawa, Manabu |e verfasserin |4 aut | |
| 700 | 1 | |a Beppu, Mikiya |e verfasserin |4 aut | |
| 700 | 1 | |a Toyoda, Kazunori |e verfasserin |4 aut | |
| 700 | 1 | |a Matsumaru, Yuji |e verfasserin |4 aut | |
| 700 | 1 | |a Matsumoto, Yasushi |e verfasserin |4 aut | |
| 700 | 1 | |a Todo, Kenichi |e verfasserin |4 aut | |
| 700 | 1 | |a Hayakawa, Mikito |e verfasserin |4 aut | |
| 700 | 1 | |a Shindo, Seigo |e verfasserin |4 aut | |
| 700 | 1 | |a Ota, Shinzo |e verfasserin |4 aut | |
| 700 | 1 | |a Morimoto, Masafumi |e verfasserin |4 aut | |
| 700 | 1 | |a Takeuchi, Masataka |e verfasserin |4 aut | |
| 700 | 1 | |a Imamura, Hirotoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Ikeda, Hiroyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Tanaka, Kanta |e verfasserin |4 aut | |
| 700 | 1 | |a Ishihara, Hideyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Kakita, Hiroto |e verfasserin |4 aut | |
| 700 | 1 | |a Sano, Takanori |e verfasserin |4 aut | |
| 700 | 1 | |a Araki, Hayato |e verfasserin |4 aut | |
| 700 | 1 | |a Nomura, Tatsufumi |e verfasserin |4 aut | |
| 700 | 1 | |a Sakakibara, Fumihiro |e verfasserin |4 aut | |
| 700 | 1 | |a Yoshimura, Shinichi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of neurointerventional surgery |d 2009 |g (2023) vom: 30. Aug. |w (DE-627)NLM19772521X |x 1759-8486 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:30 |g month:08 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/jnis-2023-020670 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 30 |c 08 | ||